Literature DB >> 32016038

Paradigm shift in local consolidative therapy for oligometastatic non-small cell lung cancer: a meta-analysis.

Christopher Cao1,2,3,4, Adam Chakos3, Allen Guo3, John J Park5, Tajalli Saghaie6, Prunella Blinman7.   

Abstract

Entities:  

Year:  2019        PMID： 32016038      PMCID： PMC6976435          DOI： 10.21037/atm.2019.09.147

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  13 in total

1.  Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis.

Authors:  David Palma; Otto Visser; Frank J Lagerwaard; Jose Belderbos; Ben J Slotman; Suresh Senan
Journal:  J Clin Oncol       Date:  2010-11-01       Impact factor: 44.544

2.  A systematic review and meta-analysis on pulmonary resections by robotic video-assisted thoracic surgery.

Authors:  Christopher Cao; Con Manganas; Su C Ang; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2012-05

3.  A meta-analysis of unmatched and matched patients comparing video-assisted thoracoscopic lobectomy and conventional open lobectomy.

Authors:  Christopher Cao; Con Manganas; Su C Ang; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2012-05

4.  Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non-Small-Cell Lung Cancer.

Authors:  Kyle G Mitchell; Ahsan Farooqi; Ethan B Ludmir; Erin M Corsini; Jiexin Zhang; Boris Sepesi; Ara A Vaporciyan; Stephen G Swisher; John V Heymach; Jianjun Zhang; Daniel R Gomez; Mara B Antonoff
Journal:  Clin Lung Cancer       Date:  2019-08-01       Impact factor: 4.785

5.  The long-term survival of robotic lobectomy for non-small cell lung cancer: A multi-institutional study.

Authors:  Robert J Cerfolio; Asem F Ghanim; Mark Dylewski; Giulia Veronesi; Lorenzo Spaggiari; Bernard J Park
Journal:  J Thorac Cardiovasc Surg       Date:  2017-09-18       Impact factor: 5.209

6.  Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.

Authors:  David A Palma; Robert Olson; Stephen Harrow; Stewart Gaede; Alexander V Louie; Cornelis Haasbeek; Liam Mulroy; Michael Lock; George B Rodrigues; Brian P Yaremko; Devin Schellenberg; Belal Ahmad; Gwendolyn Griffioen; Sashendra Senthi; Anand Swaminath; Neil Kopek; Mitchell Liu; Karen Moore; Suzanne Currie; Glenn S Bauman; Andrew Warner; Suresh Senan
Journal:  Lancet       Date:  2019-04-11       Impact factor: 79.321

7.  Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.

Authors:  Martin Reck; Delvys Rodríguez-Abreu; Andrew G Robinson; Rina Hui; Tibor Csőszi; Andrea Fülöp; Maya Gottfried; Nir Peled; Ali Tafreshi; Sinead Cuffe; Mary O'Brien; Suman Rao; Katsuyuki Hotta; Melanie A Leiby; Gregory M Lubiniecki; Yue Shentu; Reshma Rangwala; Julie R Brahmer
Journal:  N Engl J Med       Date:  2016-10-08       Impact factor: 91.245

8.  Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.

Authors:  Patricia Guyot; A E Ades; Mario J N M Ouwens; Nicky J Welton
Journal:  BMC Med Res Methodol       Date:  2012-02-01       Impact factor: 4.615

9.  Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.

Authors:  Daniel R Gomez; George R Blumenschein; J Jack Lee; Mike Hernandez; Rong Ye; D Ross Camidge; Robert C Doebele; Ferdinandos Skoulidis; Laurie E Gaspar; Don L Gibbons; Jose A Karam; Brian D Kavanagh; Chad Tang; Ritsuko Komaki; Alexander V Louie; David A Palma; Anne S Tsao; Boris Sepesi; William N William; Jianjun Zhang; Qiuling Shi; Xin Shelley Wang; Stephen G Swisher; John V Heymach
Journal:  Lancet Oncol       Date:  2016-10-24       Impact factor: 41.316

10.  Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.

Authors:  Puneeth Iyengar; Zabi Wardak; David E Gerber; Vasu Tumati; Chul Ahn; Randall S Hughes; Jonathan E Dowell; Naga Cheedella; Lucien Nedzi; Kenneth D Westover; Suprabha Pulipparacharuvil; Hak Choy; Robert D Timmerman
Journal:  JAMA Oncol       Date:  2018-01-11       Impact factor: 31.777
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.